


Some find it difficult to fall asleep, while others find they wake up more during. A study published by Lancet Psychiatry finds that insomnia may be one of the most common neurological and psychiatric outcomes from COVID-19. It is common to experience problems with our sleeping pattern with long COVID. The era of sleep disorders spectrum in patients with COVID-19 remains to be characterized suggesting a frightening scientific association between COVID-19 and neuropsychiatric illness. COVID-19 infection may have a large neurological and psychiatric impact on as many as one-third of its survivors. Our case highlighted the rare occurrence of restless leg syndrome and insomnia during the COVID-19 pandemic. Two weeks later, the patient made a complete neurological and respiratory recovery.

The patient was treated with Oseltamivir 75mg and clarithromycin 500 mg (12 hourly for each respectively) for 10 days with paracetamol. The naso-oropharyngeal swab test for coronavirus disease 2019 (COVID-19) by qualitative real-time reverse-transcriptase-polymerase-chain-reaction assay was positive. BACKGROUND: Anxiety has been a common mental state during the epidemic of Coronavirus Disease 2019 (COVID-19) and is usually closely related to somatization. Three days before, she had developed a cough, malaise and athenia, headache, arthralgia, myalgia affecting mainly upper limbs, diarrhea and a fever followed by tachypnea. Patient data were obtained from medical records from Al-Raghy Isolation Hospital in Assuit University.Ī 49-year-old female patient presented with insomnia and restless leg syndrome associated with anosmia, ageusia. We reported one patient infected with acute respiratory syndrome coronavirus-2 (SARS-CoV-2) presented with sleep disorders insomnia and restless leg syndrome.
